Carol Spieckerman’s Retail Insights
Glp-1 Meds a Shift, Not a Shock to Retail
Carol Spieckerman Speaks with the Daily Mail on the real impact of GLP-1 drugs on retailers and suppliers and why choice is king regardless.
Carol Spieckerman Speaks with the Daily Mail on the real impact of GLP-1 drugs on retailers and suppliers and why choice is king regardless.